Condition
First Line Therapy clinical trials and research
As of November 12, 2026, Find a Trial lists 4 First Line Therapy clinical trials that are recruiting, at sites in 3 countries (most in China (2), Germany (1), Malaysia (1)). By phase: Phase 2 (2), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest First Line Therapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Fruquintinib with trastuzumab and XELOX for first-line treatment of HER2‑positive advanced stomach or GEJ cancer | Phase 1/2 | Zhengzhou, Henan | Recruiting | Jan 12, 2026 |
| Zanidatamab with pembrolizumab and chemotherapy for HER2- and PD-L1-positive metastatic gastroesophageal adenocarcinoma | Phase 2 | Berlin and 19 other locations | Recruiting | Sep 16, 2025 |
| Low‑dose nivolumab plus chemotherapy as first-line treatment for advanced or metastatic non-small cell lung cancer | Phase 3 | Alor Star, Kedah | Recruiting | Jul 3, 2025 |
| Comparing two treatment regimens for newly diagnosed acute myeloid leukemia | Phase 2 | Beijing, Beijing Municipality | Recruiting | Apr 15, 2025 |
All recruiting trials (4)
-
Fruquintinib with trastuzumab and XELOX for first-line treatment of HER2‑positive advanced stomach or GEJ cancer
This trial will try fruquintinib together with trastuzumab and XELOX to see if it helps people with HER2‑positive advanced stomach or gastroesophageal junction cancer as their first treatment.
-
Zanidatamab with pembrolizumab and chemotherapy for HER2- and PD-L1-positive metastatic gastroesophageal adenocarcinoma
This trial tests whether adding zanidatamab to pembrolizumab plus chemotherapy helps people with untreated HER2- and PD-L1-positive metastatic gastroesophageal adenocarcinoma.
-
Low‑dose nivolumab plus chemotherapy as first-line treatment for advanced or metastatic non-small cell lung cancer
This trial tests whether adding low‑dose nivolumab to standard chemotherapy helps people with advanced or metastatic non‑small cell lung cancer starting first‑line treatment.
-
Comparing two treatment regimens for newly diagnosed acute myeloid leukemia
This study is testing a new treatment for people with newly diagnosed acute myeloid leukemia to see if it works better than the standard treatment.
Related topics
Quick answers
How many First Line Therapy clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Germany (1 trial), Malaysia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.